June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017

Effects of zinc – acetlysalicylic acid complex on retinal inflammation of type 2 diabetic rats
Author Affiliations & Notes
  • Nil Celik
    Ophtalmology, University Hospital Heidelberg, Heidleberg, Germany
  • Sevil Korkmaz-Icöz
    Department of Cardiac Surgery, Heidelberg, Germany
  • Gábor Szabó
    Department of Cardiac Surgery, Heidelberg, Germany
  • Gerd Auffarth
    Ophtalmology, University Hospital Heidelberg, Heidleberg, Germany
  • Jürgen Kopitz
    Department of Pathology, Heidelberg, Germany
  • Footnotes
    Commercial Relationships   Nil Celik, Grimmke Foundation (F), Grimmke Foundation (R); Sevil Korkmaz-Icöz, None; Gábor Szabó, None; Gerd Auffarth, Alcon (F), Alcon (R), Alimera (F), Allergan (F), AMO (F), AMO (R), Bayer (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), Contamac (F), Glaukos (F), Heidelberg Engineering (F), Hoya (R), Kowa (R), Novartis (F), Novartis (R), Oculentis (F), Oculentis (R), Ophtec (R), Physiol (F), Physiol (R), Rayner (F), Rayner (R); Jürgen Kopitz, None
  • Footnotes
    Support  a small part of the accomodation
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5789. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nil Celik, Sevil Korkmaz-Icöz, Gábor Szabó, Gerd Auffarth, Jürgen Kopitz;
      Effects of zinc – acetlysalicylic acid complex on retinal inflammation of type 2 diabetic rats. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5789.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose :
Type-2 diabetics have an increased risk of macrovascular and microvascular complications including diabetic retinopathy. Hyperglycemia and inflammation are the major factors leading to severe diabetic adversitites. Ant-inflammatory and anti-diabetic medication may prevent disease progression. We investigated the impact of zinc complex of acetylsalicylic acid (Zn(ASA)2) on changes in retinal gene expression in Zucker diabetic fatty (ZDF) rats, an experimental model of type-2 diabetic retinopathy.

Methods :
At the age of 25 weeks, nondiabetic control (ZL) and obese ZDF rats were pretreated orally with vehicle or Zn(ASA)2 for 24 days. At the age of 29-30 weeks, RNA was extracted from retinas. Reverse transcription for the synthesis of cDNA was performed to determine the expression patterns of 84 selected genes involved in inflammation using micrfluidic card PCR technology (rt-PCR).

Results :
Treatement with Zn(ASA)2 significantly decreased plasma glucose concentration (39.6mM±3.1 vs 50.4mM±2.6, p<0.05). Plasma insullin levels remained similar among the groups. Compared to ZL rats, the retinal gene expression of inflammatory genes (BMP2, CCL2, CCL20, CCL3, CCL4, CCL7, CCR1, CCR3, CXCL10, CXCL6, CXCL9, FASLG, IL13, IL15, IL17A, IL17B, IL1B, IL33, IL4, TNF, VEGF-A and VFRSF11B) were at least two fold higher in ZDF rats. In contrast to the vehicle group, genes related to the inflammatory response (CCL2, CCL20, CCL3, CXCL6, IL13, IL17A and VEGF-A) were significantly decreased in obese ZDF rats.

Conclusions :
Zn(ASA)2 sustains glucose metabolism. Retinal inflammation has a severe impact on ZDF rats diabetic retinopathy. The anti-inflammatory effect of Zn(ASA)2 reversed changes in gene expression in diabetic retinopathy of ZDF rats.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.